Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (248)
  3. Review (13)
  4. Guidelines (11)
  5. Research Letter (9)
  6. Book Section (6)
  7. Correspondence (5)
  8. Editorial (4)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (671)
  2. Department of Medicine (671)
  3. Hematologic Malignancies, Division of (671)
  4. Lymphoma (671)
  5. Population Sciences Research Program (671)
  6. Survivorship Research (173)

More Groups

People
  1. Alison Moskowitz (235)
  2. Andrew Zelenetz (169)
  3. Paul Hamlin (140)
  4. Ariela Noy (139)
  5. David Straus (122)
  6. Maria Palomba (112)

More People

Years
  1. 2025 (18)
  2. 2024 (51)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Blood Advances (19)
  5. Leukemia and Lymphoma (19)
  6. Annals of Oncology (18)

More Publications

Publishers
  1. American Society of Hematology (277)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (34)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (23)

More Publishers

Results (671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes and prognostic factors in African American/Black patients with mycosis fungoides and Sézary syndrome
    Meeting Abstract

    Geller, S.; Lebowitz, E.; Pulitzer, M. P.; Horwitz, S. M.; Moskowitz, A. J.; Dusza, S.; Myskowski, P. L.
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
    Journal Article

    Kurzrock, R.; Gurski, L. A.; Carlson, R. W.; Ettinger, D. S.; Horwitz, S. M.; Kumar, S. K.; Million, L.; von Mehren, M.; Benson, A. B. 3rd
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • TFH lymphomas: The times they aza-changin'?
    Editorial

    Weinstock, D. M.; Horwitz, S. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B-cell lymphomas
    Meeting Abstract

    Jagadeesh, D.; Horwitz, S. M.; Bartlett, N. L.; Advani, R. H.; Jacobsen, E. D.; Duvic, M.; Gautam, A.; Rao, S.; Onsum, M.; Fanale, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants
    Meeting Abstract

    Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q. Y.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to A+CHP by CD30 expression in the ECHELON-2 trial
    Meeting Abstract

    Advani, R. H.; Horwitz, S. M.; Iyer, S. P.; Bartlett, N. L.; Kim, W. S.; Tilly, H.; Belada, D.; Feldman, T.; Illés, A.; Jacobsen, E. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CCR4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders and its implications for diagnosis and treatment
    Meeting Abstract

    Geller, S.; Hollmann, T. J.; Horwitz, S. M.; Myskowski, P. L.; Pulitzer, M.
    Journal of Investigative Dermatology (2019)

    Fulltext@MSK | Save
  • Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
    Journal Article

    Kheterpal, M. K.; Dai, J.; Geller, S.; Pulitzer, M.; Ni, A.; Myskowski, P. L.; Moskowitz, A.; Kim, J.; Hong, E. K.; Fong, S.; more...
    Journal of the American Academy of Dermatology (2019)

    Fulltext@MSK | Save
  • Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
    Journal Article

    Taylor, J.; Haddadin, M.; Upadhyay, V. A.; Grussie, E.; Mehta-Shah, N.; Brunner, A. M.; Louissaintr, A. Jr; Lovitch, S. B.; Dogan, A.; Fathi, A. T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Efficacy of mogamulizumab in patients with previously treated cutaneous T-cell lymphoma: Post hoc analysis from the phase III MAVORIC study
    Meeting Abstract

    Scarisbrick, J.; Zinzani, P. L.; Horwitz, S.; Kim, Y. H.; Moskowitz, A. J.; Porcu, P.; Leoni, M.; Dwyer, K.; Sun, W.; Nikonova, E.; more...
    British Journal of Dermatology (2019)

    Fulltext@MSK | Save